Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1974 1
1975 7
1976 21
1977 11
1978 14
1979 14
1980 11
1981 13
1982 8
1983 11
1984 9
1985 8
1986 10
1987 13
1988 17
1989 11
1990 9
1991 10
1992 8
1993 7
1994 6
1995 6
1996 6
1997 5
1998 6
1999 9
2000 3
2001 16
2002 7
2003 8
2004 9
2005 16
2006 14
2007 13
2008 20
2009 12
2010 21
2011 14
2012 20
2013 10
2014 12
2015 11
2016 18
2017 14
2018 12
2019 18
2020 18
2021 16
2022 9
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

549 results

Results by year

Filters applied: . Clear all
Page 1
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy.
Rossing P, Filippatos G, Agarwal R, Anker SD, Pitt B, Ruilope LM, Chan JCN, Kooy A, McCafferty K, Schernthaner G, Wanner C, Joseph A, Scheerer MF, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Among authors: schernthaner g. Kidney Int Rep. 2021 Oct 14;7(1):36-45. doi: 10.1016/j.ekir.2021.10.008. eCollection 2022 Jan. Kidney Int Rep. 2021. PMID: 35005312 Free PMC article.
From the eye into the foot?
Hafner J, Zierfuss B, Schernthaner GH, Schmidt-Erfurth U. Hafner J, et al. Among authors: schernthaner gh. Atherosclerosis. 2020 Feb;294:41-43. doi: 10.1016/j.atherosclerosis.2019.12.007. Epub 2019 Dec 13. Atherosclerosis. 2020. PMID: 31932032 No abstract available.
Chronic complications of venous thromboembolism.
Winter MP, Schernthaner GH, Lang IM. Winter MP, et al. Among authors: schernthaner gh. J Thromb Haemost. 2017 Aug;15(8):1531-1540. doi: 10.1111/jth.13741. J Thromb Haemost. 2017. PMID: 28762624 Free article. Review.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: schernthaner g. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
The right place for metformin today.
Schernthaner G, Schernthaner GH. Schernthaner G, et al. Among authors: schernthaner gh. Diabetes Res Clin Pract. 2020 Jan;159:107946. doi: 10.1016/j.diabres.2019.107946. Epub 2019 Nov 26. Diabetes Res Clin Pract. 2020. PMID: 31778746 Review.
[Injection therapy of diabetes].
Lechleitner M, Roden M, Weitgasser R, Ludvik B, Fasching P, Hoppichler F, Kautzky-Willer A, Schernthaner G, Prager R, Kaser S, Wascher TC; Ausschuss Leitlinien. Lechleitner M, et al. Among authors: schernthaner g. Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):45-52. doi: 10.1007/s00508-023-02171-x. Epub 2023 Apr 20. Wien Klin Wochenschr. 2023. PMID: 37101024 Free PMC article. German.
Hypoglycemia and cardiovascular risks.
Frier BM, Schernthaner G, Heller SR. Frier BM, et al. Among authors: schernthaner g. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S132-7. doi: 10.2337/dc11-s220. Diabetes Care. 2011. PMID: 21525444 Free PMC article. Review. No abstract available.
Testosterone and Peripheral Arterial Disease.
Blinc A, Schernthaner GH, Poredoš P, Anagnostis P, Jensterle M, Studen KB, Antignani PL, Mikhailidis DP, Šabović M. Blinc A, et al. Among authors: schernthaner gh. Curr Vasc Pharmacol. 2023;21(5):297-303. doi: 10.2174/1570161121666230809143023. Curr Vasc Pharmacol. 2023. PMID: 37559242
Diabetes and bone.
Pietschmann P, Patsch JM, Schernthaner G. Pietschmann P, et al. Among authors: schernthaner g. Horm Metab Res. 2010 Oct;42(11):763-8. doi: 10.1055/s-0030-1262825. Epub 2010 Aug 13. Horm Metab Res. 2010. PMID: 20711953 Review.
[Diabetic nephropathy--update 2012].
Auinger M, Edlinger R, Prischl F, Kautzky-Willer A, Prager R, Rosenkranz AR, Roden M, Saemann M, Clodi M, Schernthaner G. Auinger M, et al. Among authors: schernthaner g. Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:42-9. doi: 10.1007/s00508-012-0262-6. Wien Klin Wochenschr. 2012. PMID: 23262747 German.
549 results